Our comprehensive work complements the existing research on PRC2, particularly the extensively studied EZH2 subunit, which is known for its involvement in the epigenetic silencing of tumor suppressor genes and promotion of cancer progression [101]. The gene discussed is EZH2; the disease is cancer.